Your session is about to expire
← Back to Search
Early Exercise for Stroke (BEACH Trial)
BEACH Trial Summary
This trial will compare the inflammatory factors of two groups of brain hemorrhage patients, one of which will receive in-bed cycling in addition to usual care.
BEACH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BEACH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have bleeding in the brain, either inside or around it.You have a score between 0 and 2 on the modified Rankin Scale before you got sick.You have injuries in your legs or hips, or you weigh more than 250 kilograms and cannot use the cycle normally.You have an ongoing infection, inflammation, or are pregnant.You have a very low Glasgow Coma Score (GCS) within 48 hours of being admitted.You are currently taking certain anti-inflammatory medications every day.Your family is thinking about taking you off life support.
- Group 1: Control
- Group 2: Supine cycle ergometry of the lower extremities
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available slots for participants in this research?
"Per the clinicaltrials.gov website, this experiment is actively seeking participants at present. First posted on March 2nd 2019, it was last modified on January 6th 2022."
How many individuals have enrolled in this research endeavor?
"Affirmative. The clinical trial is recruiting as indicated on the clinicaltrials.gov website, which was last updated in January 6th 2022 and initially posted on March 2nd 2019. This medical study requires 40 participants at a single site."
What are the main aims of this research endeavor?
"The primary aim of this experiment, which will be assessed on Day 1, 3 and 7, is to measure the amount of interleukin-1beta in the blood. Secondary endpoints include Functional status as measured by a Modified Rankin Score (MRS) rating from 0-6 (with 6 indicating death), fatigue as evaluated using Promis Scale v1.2 with higher scores illustrating less weariness, and Hand-held dynamometry score (pounds)."
Share this study with friends
Copy Link
Messenger